Vonoprazan vs Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vonoprazan vs Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-10-10
DOI
10.1053/j.gastro.2022.09.041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. SUBJECTS
- (2022) Loren Laine et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
- (2021) Philip O. Katz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
- (2021) Anne F. Peery et al. GASTROENTEROLOGY
- Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis
- (2020) Jorabar Singh Nirwan et al. Scientific Reports
- Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
- (2019) Yinglian Xiao et al. GUT
- Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
- (2018) Kiyoshi Ashida et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
- (2018) Janusz A Z Jankowski et al. LANCET
- The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase
- (2015) D. R. Scott et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
- (2015) L. Lundell et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
- (2013) Jai Moo Shin et al. Journal of Neurogastroenterology and Motility
- Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis
- (2009) D. C. METZ et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- No Association Between Gastric Fundic Gland Polyps and Gastrointestinal Neoplasia in a Study of Over 100,000 Patients
- (2009) Robert M. Genta et al. Clinical Gastroenterology and Hepatology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started